l Getting Certified
Educating Patients
Medication Guides
Prescribing Information
Getting Certified

Under the Drug Addiction Treatment Act of 2000 (DATA 2000), prescription use of buprenorphine-containing products in the treatment of opioid dependence is limited to prescribers who meet certain qualifying requirements, and who have notified the Secretary of Health and Human Services (HHS) of their intent to prescribe this product for the treatment of opioid dependence and have been assigned a unique identification number that must be included on every prescription.

To become certified to prescribe buprenorphine-containing products, you will need to follow certification guidelines set by DATA 2000.

Detailed information about DATA 2000, qualifications, notifying SAMHSA, and the general prescriber waiver process can be found at www.samhsa.gov, or by contacting SAMHSA directly:

SAMHSA Buprenorphine Information Center
Phone: 1-866-287-2728 (866-BUP-CSAT)
E-mail: infobuprenorphine@samhsa.hhs.gov
This REMS does not apply to buprenorphine-containing products indicated for the treatment of pain or for products dispensed to patients admitted to Opioid Treatment Programs (OTP) under 42 CFR part 8.

Last Updated May 2022